SCHEMBL24064580

SCHEMBL24064580

CC(C)(C)OC(=O)NCCOCCOCCOCCOC(=O)c1cccnc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.52
LMNA P02545 5/20 0.50
CYP3A4 P08684 3/20 0.49
KMT2A Q03164 3/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
USP2 O75604 1/20 0.49
MEN1 O00255 1/20 0.49
CYP1A2 P05177 1/20 0.49
POLB P06746 1/20 0.47
ALDH1A1 P00352 4/20 0.47
MAPT P10636 3/20 0.47
CYP2C9 P11712 1/20 0.47
PKM P14618 1/20 0.47
CYP2C19 P33261 1/20 0.47
NAMPT P43490 1/20 0.47
RXFP1 Q9HBX9 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
KDM4E B2RXH2 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
HSD17B10 Q99714 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25332560 0.93 L3MBTL1 (0.56) L3MBTL1LMNACYP3A4KMT2ASMN1; SMN2
SCHEMBL25028453 0.88 KMT2A (0.60) LMNACYP3A4KMT2ASMN1; SMN2USP2
SCHEMBL6523383 0.87 KMT2A (0.62) LMNACYP3A4KMT2ASMN1; SMN2USP2
SCHEMBL28868029 0.86 IDO1 (0.54) LMNASMN1; SMN2MAPTTDP1
SCHEMBL24064584 0.84 L3MBTL1 (0.52) L3MBTL1LMNACYP3A4KMT2ASMN1; SMN2
SCHEMBL21423578 0.82 CYP3A4 (0.51) L3MBTL1LMNACYP3A4KMT2ASMN1; SMN2
SCHEMBL28099067 0.80 CYP3A4 (0.51) L3MBTL1LMNACYP3A4KMT2AMEN1
SCHEMBL3402444 0.79 RAB9A (0.61) CYP3A4KMT2ASMN1; SMN2USP2MEN1
SCHEMBL23928824 0.79 CYP3A4 (0.60) LMNACYP3A4SMN1; SMN2ALDH1A1MAPT
SCHEMBL8457758 0.78 IDO1 (0.62) LMNASMN1; SMN2ALDH1A1MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210371446-A1 SIRT1 ACTIVATING COMPOUNDS PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2021-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210371446-A1 SIRT1 ACTIVATING COMPOUNDS SIRT1, SIRT2, SIRT3 L3MBTL1 2991/4885LMNA 881/4885CYP3A4 4172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.